Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2017
Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab ExposureAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
British Journal of Haematology|December 15, 2018
Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO groupAlba M Redondo, David Valcárcel, Ana P González-Rodríguez, et al.
Leukemia & Lymphoma|August 30, 2021
A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up resultsArmando López-Guillermo, Miguel Ángel Canales, Ivan Dlouhy, et al.
European Journal of Haematology|December 17, 2019
Use of eltrombopag for patients 65 years old or older with immune thrombocytopeniaTomás José González-López, Blanca Sánchez-González, Isidro Jarque, et al.
Hematology/Oncology and Stem Cell Therapy|July 19, 2019
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapyAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Scientific Reports|November 15, 2019
Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopeniaMaria L Lozano, Maria E Mingot-Castellano, María M Perera, et al.
Blood|September 6, 2019
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myelomaLaura Rosiñol, Albert Oriol, Rafael Rios, et al.
British Journal of Haematology|December 19, 2014
Use of eltrombopag after romiplostim in primary immune thrombocytopeniaJosé Ramón González-Porras, María Eva Mingot-Castellano, Marcio M Andrade, et al.
Blood|July 28, 2023
Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myelomaLaura Rosiñol, Albert Oriol, Rafael Ríos, et al.
European Journal of Haematology|December 29, 2015
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practiceTomás José González-López, María Teresa Alvarez-Román, Cristina Pascual, et al.
Pageof 12